Home Beauty Health Seaweed-derived drug therapeutically remodels gut microbiome and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression in a mouse model. The drug is undergoing Phase 3 human clinical trials and has just been approved to treat Alzheimer’s in China.

on November 05, 2019
Seaweed-derived drug therapeutically remodels gut microbiome and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression in a mouse model. The drug is undergoing Phase 3 human clinical trials and has just been approved to treat Alzheimer’s in China. submitted by /u/mvea
[link] [comments]


from Health https://ift.tt/2POSn0Y
,
Share To:

Unknown

View Profile

Post A Comment:

0 comments so far,add yours

Subscribe to: Post Comments (Atom)